Steward Partners Investment Advisory, LLC Sorrento Therapeutics, Inc. Transaction History

Steward Partners Investment Advisory, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$0.17 - $1.19 $425 - $2,975	-2,500 Reduced 55.56%	2,000 $0
Q4 2021 Feb 08, 2022	SELL	$4.65 - $7.23 $6,035 - $9,384	-1,298 Reduced 22.39%	4,500 $21,000
Q2 2021 Aug 13, 2021	SELL	$6.35 - $10.0 $15,240 - $24,000	-2,400 Reduced 29.28%	5,798 $56,000
Q1 2021 May 14, 2021	BUY	$7.03 - $16.51 $9,842 - $23,114	1,400 Added 20.59%	8,198 $67,000
Q3 2020 Oct 30, 2020	BUY	$6.17 - $18.82 $20,348 - $62,068	3,298 Added 94.23%	6,798 $76,000
Q2 2020 Aug 06, 2020	BUY	$1.73 - $6.76 $6,055 - $23,660	3,500 New	3,500 $22,000

5.47M

Ticker SRNE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 449,952,000
Market Cap $148M
Description
Sorrento Therapeutics, Inc., a clinical stage and commercial biopharmaceutical company, develops therapies for cancer, autoimmune, inflammatory, viral, and neurodegenerative diseases. It operates through two segments, Sorrento Therapeutics and Scilex. The company provides cancer therapeutic by leveraging its proprietary G-MAB antibody library an...

Get notified when there are updates to the investment portfolio of Steward Partners Investment Advisory, LLC, based on Form 13F filings with the SEC.

Stay updated on Steward Partners Investment Advisory, LLC with notifications on news.